相似文献
1
Under the Influence: Cognitive Effects of Medical Marijuana on Developing Minds.
J Pediatr Pharmacol Ther. 2025 Aug;30(4):440-449. doi: 10.5863/JPPT-25-01209. Epub 2025 Aug 11.
3
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
Cochrane Database Syst Rev. 2015 Nov 12;2015(11):CD009464. doi: 10.1002/14651858.CD009464.pub2.
4
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.
Cochrane Database Syst Rev. 2013 Apr 30(4):CD005175. doi: 10.1002/14651858.CD005175.pub3.
5
[Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Epidemiol Prev. 2017 Sep-Dec;41(5-6):279-293. doi: 10.19191/EP17.5-6.AD01.069.
6
Cannabis and schizophrenia.
Cochrane Database Syst Rev. 2014 Oct 14;2014(10):CD004837. doi: 10.1002/14651858.CD004837.pub3.
7
The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.
Eur J Intern Med. 2018 Mar;49:7-11. doi: 10.1016/j.ejim.2018.01.003. Epub 2018 Jan 9.
8
Pain management for women in labour: an overview of systematic reviews.
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD009234. doi: 10.1002/14651858.CD009234.pub2.
9
Antidepressants for chronic non-cancer pain in children and adolescents.
Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012535. doi: 10.1002/14651858.CD012535.pub2.
10
Cannabis and cannabinoid-microbiome interactions in varied clinical contexts: A comprehensive systematic review.
Biomed Pharmacother. 2025 Jan;182:117764. doi: 10.1016/j.biopha.2024.117764. Epub 2024 Dec 16.
本文引用的文献
1
An Opportunity to Advance Cannabis Science-DEA Rescheduling.
JAMA Psychiatry. 2025 Apr 1;82(4):331-332. doi: 10.1001/jamapsychiatry.2024.4691.
2
It's Not "Just Weed" Anymore.
J Med Chem. 2024 Sep 12;67(17):14697-14699. doi: 10.1021/acs.jmedchem.4c01854. Epub 2024 Aug 15.
3
Prenatal Cannabis Use and Maternal Pregnancy Outcomes.
JAMA Intern Med. 2024 Sep 1;184(9):1083-1093. doi: 10.1001/jamainternmed.2024.3270.
4
Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.
Epilepsia Open. 2024 Oct;9(5):1632-1642. doi: 10.1002/epi4.12956. Epub 2024 Jul 15.
5
The prevalence of chronic pain in children and adolescents: a systematic review update and meta-analysis.
Pain. 2024 Oct 1;165(10):2215-2234. doi: 10.1097/j.pain.0000000000003267. Epub 2024 May 15.
6
Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine.
Pharmaceutics. 2024 Feb 7;16(2):241. doi: 10.3390/pharmaceutics16020241.
7
Experience With Medical Marijuana in a Pediatric Palliative Care Clinic: Case Report.
J Pain Symptom Manage. 2024 Apr;67(4):e361-e365. doi: 10.1016/j.jpainsymman.2024.01.031. Epub 2024 Jan 24.
8
Cannabidiol and Intestinal Motility: a Systematic Review.
Curr Dev Nutr. 2023 Jul 17;7(10):101972. doi: 10.1016/j.cdnut.2023.101972. eCollection 2023 Oct.
9
Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns.
Pharmaceutics. 2023 Apr 5;15(4):1151. doi: 10.3390/pharmaceutics15041151.
10
Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks.
Pain Ther. 2023 Apr;12(2):355-375. doi: 10.1007/s40122-022-00465-y. Epub 2023 Jan 13.
Zotero 插件